Hudson Holds Reins As Sanofi Makes Strides To Become R&D Powerhouse

Paul Hudson, who has just celebrated his five year anniversary as CEO of Sanofi, feels that the firm is well on the way to being regarded as an elite R&D company, an area where it has lagged behind the industry’s research-based heavyweights.

Speaking to Scrip at Sanofi’s headquarters in central Paris, he said: “It is only now that I feel we’re now at the start line, because for 20 or 30 years (the company is 52 years old), we were not seen as a scientific leader